| |
| |
|
| Insider
Information: |
Hayden Michael R |
| Relationship: |
Director |
| City: |
Burnaby |
| State: |
A1 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
322,329 |
|
|
Indirect Shares
|
1,711,659 |
|
|
| Direct
Value |
$2,362,532 |
|
|
|
Indirect Value
|
$614,156 |
|
|
| Total
Shares |
2,033,988 |
|
|
| Total
Value |
$2,976,688 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
0
|
|
Stock
price went up :
|
3
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
3.0
|
0.0
|
| Percentage
Gain/Loss : |
 183.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Xenon Pharmaceuticals Inc. |
XENE |
Director |
2021-05-18 |
116,206 |
2021-05-18 |
206,479 |
Premium* |
|
|
Ionis Pharmaceuticals Inc |
IONS |
Director |
2023-07-17 |
30,219 |
2023-07-17 |
2,000 |
Premium* |
|
|
89bio, Inc. |
ETNB |
|
2023-03-28 |
80,904 |
2023-03-28 |
61,538 |
Premium* |
|
|
Abcellera Biologics Inc. |
ABCL |
Director |
|
0 |
2023-09-22 |
1,441,642 |
Premium* |
|
|
Aurinia Pharmaceuticals Inc |
AUPH |
Director |
2021-01-29 |
95,000 |
2021-01-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
39 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ABCL |
Abcellera Biologics Inc. |
Director |
– • – |
2020-12-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,030,330 |
|
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2014-11-09 |
4 |
A |
$0.00 |
$0 |
I/I |
14,227 |
75,886 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2018-02-22 |
4 |
GA |
$0.00 |
$0 |
I/I |
21,180 |
97,066 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2018-02-22 |
4 |
GD |
$0.00 |
$0 |
D/D |
29,580 |
131,607 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2019-03-11 |
4 |
GD |
$0.00 |
$0 |
D/D |
24,045 |
107,562 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2019-03-11 |
4 |
GA |
$0.00 |
$0 |
I/I |
17,337 |
114,403 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2019-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,778 |
1,778 |
0 |
- |
|
| ETNB |
89bio, Inc. |
Director |
– • – |
2019-11-13 |
4 |
A |
$0.00 |
$0 |
I/I |
58,978 |
77,728 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2020-07-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,778 |
3,556 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2020-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,778 |
5,334 |
0 |
- |
|
| ABCL |
Abcellera Biologics Inc. |
Director |
– • – |
2020-12-15 |
4 |
A |
$0.00 |
$0 |
I/I |
117,647 |
1,103,397 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2021-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,111 |
12,445 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2021-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,777 |
14,222 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2022-07-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,110 |
21,332 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2022-10-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,777 |
23,109 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Director |
– • – |
2023-07-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,110 |
30,219 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2021-05-18 |
4 |
OE |
$3.85 |
$13,475 |
D/D |
3,500 |
116,206 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2021-02-16 |
4 |
OE |
$2.68 |
$13,786 |
D/D |
5,144 |
112,706 |
0 |
- |
|
| ETNB |
89bio, Inc. |
|
– • – |
2022-03-30 |
4 |
B |
$3.62 |
$22,625 |
I/I |
6,250 |
83,978 |
0.01 |
% |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2015-02-03 |
4 |
OE |
$4.81 |
$24,743 |
I/I |
5,144 |
10,288 |
0 |
- |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2015-01-08 |
4 |
OE |
$4.98 |
$25,617 |
I/I |
5,144 |
5,144 |
0 |
- |
|
| ETNB |
89bio, Inc. |
|
– • – |
2022-04-25 |
4 |
B |
$2.67 |
$26,700 |
I/I |
10,000 |
103,978 |
0.01 |
% |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2016-05-25 |
4 |
OE |
$3.30 |
$27,159 |
I/I |
8,230 |
18,518 |
0 |
- |
|
| ETNB |
89bio, Inc. |
|
– • – |
2022-04-07 |
4 |
B |
$3.48 |
$34,750 |
I/I |
10,000 |
93,978 |
0.01 |
% |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2017-03-14 |
4 |
OE |
$3.07 |
$40,711 |
I/I |
11,830 |
30,348 |
0 |
- |
|
39 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
